Google has released Beta 4 — the last scheduled beta before stable. It fixed over a dozen critical bug, from charging ...

Android is the most used mobile operating system on the planet. In Canada, the split with iOS is closer than the global ...

Abstract: This paper investigates the potential of using Large Language Models (LLM) to automate code verification in Android development process. Android’s development process often involves creating ...

Sanuj is a freelance tech journalist with over six years of experience covering smartphones, wearables, and consumer technology. He currently writes for Android Police, Tom's Guide, Android Central, ...

Google is trying to defuse one of the sharpest criticisms of its new Android developer verification regime. The company announced it is creating a formal path for users to keep sideloading apps from ...

Editorial Note: Talk Android may contain affiliate links on some articles. If you make a purchase through these links, we will earn a commission at no extra cost to you. Learn more. Are you still ...

Java is becoming more popular for building AI applications, with 62% of respondents in Azul’s just-released 2026 State of Java Survey and Report relying on Java for AI development. Last year’s report ...

Evaluating LLMs for mobile programming tasks has become easier with Google introducing a leaderboard that benchmarks how well AI models handle Android development. Engineering teams often struggle to ...

Blender's work on a native iPad version of its open source 3D creation suite has been shelved, according to the development team. Back in July, Blender revealed that it was developing for iPad, with ...

Starting in September 2026, any developer distributing apps outside Google’s Play Store who has not registered their identity with Google will find their software blocked from running on virtually ...

Following the Gemini automation announcement today, Google is detailing how all this works under the hood on Android. Google is “introducing early stage developer capabilities that bridge the gap ...

Antibody–drug conjugates (ADCs) are biomolecules — usually monoclonal antibodies (mAbs) — that are bound to a small drug molecule through a chemical linker. ADCs are targeted therapies; the mAb ...